All the latest news and stories about Alzheimer's disease, dementia and the brain.
Canada must take action now on dementia: Recommendations to help lower risks in an aging population
A new study predicts a significant increase in the number of Canadians living with dementia over the next three decades.
The world doesn’t end when you have Alzheimer’s: Michael and Isabel’s story, continued
In 2019, Michael Phillips shared the story of him and his wife Isabel, who was diagnosed with Alzheimer’s disease in 2011. Now, three years later, Michael returns to give an update on how Isabel is doing and what challenges they faced with long-term care throughout the pandemic.
Nominations open for the National Dementia-Friendly Communities awards!
We are currently accepting nominations for our inaugural National Dementia-Friendly Communities Awards. If you know of an individual or group who is doing dementia-friendly work and is inspiring others to do the same, we’d love to hear from you!
Statement from the Alzheimer Society of Canada regarding Science article on dementia research
On July 21, Science published an article detailing possible misconduct in some influential 2006 US research on the potential cause of Alzheimer’s disease. These reports have raised questions about the overall nature of funding research on the causes of Alzheimer's disease.
Research and patient services need to reflect that Canadians from diverse communities are living with dementia
Recent data from Statistics Canada on our country’s demographic shift to an aging population highlights Canada’s evolving future. How we respond to these changes will determine our long-term success as a nation, especially for future generations of older individuals.
New report highlights the unique challenges facing 2SLGBTQI people living with dementia
In the report, Egale Canada and National Institute on Ageing researchers ask: What are the unique experiences and needs of two-spirit, lesbian, gay, bisexual, transgender, queer, and intersex (2SLGBTQI) people living with dementia and those who care for them?
Alzheimer Society of Canada position on aducanumab decision
The Alzheimer Society of Canada has been made aware of the decision by Biogen Canada Inc. to withdraw its submission of aducanumab from regulatory review by Health Canada as a treatment for people living with early stages of Alzheimer’s disease.